https://pittplusme.org/study/1738
Bullous Pemphigoid Study
We're sorry. This study is closed and no longer recruiting participants.
STUDY BASICS
Do you have bullous pemphigoid? If so, you may be able to participate in a study to help find out whether an investigational study drug called dupilumab is effective and safe for the treatment of bullous pemphigoid. This study will involve up to 24 in-person visits over up to 50 weeks. Compensation is provided.
IRB: 20193092
- A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF DUPILUMAB IN ADULT PATIENTS WITH BULLOUS PEMPHIGOID
AGE:
18 - 90
DURATION:
Up to 50 weeks
VISITS:
Up to 24 in-person visits
LOCATION:
Falk Medical Building - Oakland
COMPENSATION:
$75.00 for each completed study visit, excluding visits 11, 13, 15, 17 and 19
SHARE STUDY
